<div class="container-fluid visualization">

  <div class="top-div">
    <div class="widget-div">
      <div class="row">
        <div class="col-md-4 col-sm-4 col-xs-4">
          <div class="widget-headers">
            <div class="panel-body">
              <div class="widget-icon">
                <img src="/img/summary_icons/key_note.png">
              </div>
              <a ui-sref="dashboard.trackweekly({tabName: ''})">Key News & Competitor Alerts</a>
            </div>
          </div>
          <div class="widget-data">
            <div class="panel panel-default" style="border-bottom: 4px solid #8bc34a;">
              <div class="panel-body">
                <div class="title">
                  AACE/ACE Publish 2017 T2DM Treatment Algorithm
                </div>
                <div class="content">
                  Liraglutide and empagliflozin have both been called out for a possible benefit in CHF, ASCVD, and renal outcomes
                </div>
                <a href="#" style="color: #8bc34a; font-size: smaller;">Clinical trail Summary</a>
              </div>
            </div>

            <div class="panel panel-default" style="border-bottom: 4px solid #f8b118;">
              <div class="panel-body">
                <div class="title">
                  Canagliflozin (CANVAS) trial
                </div>
                <div class="content">
                  A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of JNJ-28431754 on Cardiovascular
                </div>
                <a href="#" style="color: #f8b118; font-size: smaller;">Reports</a>
              </div>
            </div>

            <div class="panel panel-default" style="border-bottom: 4px solid #8bc34a;">
              <div class="panel-body">
                <div class="title">
                  JPM Healthcare Conference Day 1 and 2 Coverage
                </div>
                <div class="content">
                  Liraglutide and empagliflozin have both been called out for a possible benefit in CHF, ASCVD, and renal outcomes
                </div>
                <a href="#" style="color: #8bc34a; font-size: smaller;">Clinical trail Summary</a>
              </div>
            </div>

            <div class="panel panel-default" style="border-bottom: 4px solid #f8b118;">
              <div class="panel-body">
                <div class="title">
                  Dapagliflozin (DERIVE) trial
                </div>
                <div class="content">
                  A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase III Study to Evaluate the Glycemic
                </div>
                <a href="#" style="color: #f8b118; font-size: smaller;">Reports</a>
              </div>
            </div>

            <div class="panel panel-default" style="border-bottom: 4px solid #ededed;">
              <div class="panel-body">
                <div class="title">
                  Dapagliflozin (DERIVE) trial
                </div>
                <div class="content">
                  A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase III Study to Evaluate the Glycemic
                </div>
                <a href="#" style="color: #8bc34a; font-size: smaller;">Reports</a>
              </div>
            </div>

          </div>
        </div>
        <div class="col-md-5 col-sm-5 col-xs-5">
          <div class="widget-headers">
            <div class="panel-body">
              <div class="widget-icon">
                <img src="/img/summary_icons/social_pulse.png">
              </div>
              <a ui-sref="dashboard.tracksocial({tabName: ''})">Social Pulse</a>
            </div>
          </div>
          <div class="widget-data">
            <div class="panel panel-default">
              <div class="panel-body">
                <table class="table table-striped">
                  <thead>
                    <tr style="color: #004269;">
                      <th style="text-align: left"></th>
                      <th>Overall Buzz</th>
                      <th># of shares/retweets</th>
                      <th>Mentions in target websites/ forums</th>
                      <th>Sentiment</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td width="18%">Intarcia</td>
                      <td ><i class="fa fa-long-arrow-up" aria-hidden="true" style="color: #8bc34a;"></i>19</td>
                      <td ><i class="fa fa-long-arrow-down" aria-hidden="true" style="color: #fdd835;"></i>0</td>
                      <td > <i class="fa fa-long-arrow-up" aria-hidden="true" style="color: #8bc34a;"></i>8</td>
                      <td><img src="/img/summary_icons/happy.png"></td>
                    </tr>
                    <tr>
                      <td width="18%">Jardiance</td>
                      <td><i class="fa fa-long-arrow-down" aria-hidden="true" style="color: #fdd835;"></i>65</td>
                      <td><i class="fa fa-long-arrow-down" aria-hidden="true" style="color: #fdd835;"></i>320</td>
                      <td><i class="fa fa-long-arrow-down" aria-hidden="true" style="color: #fdd835;"></i>45
                      </td>
                      <td><img src="/img/summary_icons/sad.png"></td>
                    </tr>
                    <tr>
                      <td width="18%">Invokana</td>
                      <td ><i class="fa fa-long-arrow-down" aria-hidden="true" style="color: #fdd835;"></i>86</td>
                      <td ><i class="fa fa-long-arrow-down" aria-hidden="true" style="color: #fdd835;"></i>432</td>
                      <td><i class="fa fa-long-arrow-up" aria-hidden="true" style="color: #8bc34a;"></i>52
                      </td>
                      <td><img src="/img/summary_icons/zero.png"></td>
                    </tr>
                    <tr>
                      <td width="18%">Janumet</td>
                      <td ><i class="fa fa-long-arrow-up" aria-hidden="true" style="color: #8bc34a;"></i> 66</td>
                      <td><i class="fa fa-long-arrow-up" aria-hidden="true" style="color: #8bc34a;"></i>467</td>
                      <td><i class="fa fa-long-arrow-up" aria-hidden="true" style="color: #8bc34a;"></i>52
                      </td>
                      <td><img src="/img/summary_icons/happy.png"></td>
                    </tr>
                  </tbody>
                </table>
              </div>
            </div>
            <a ui-sref="dashboard.trackweekly({tabName: ''})" class="pull-right" style="font-size: smaller;">View More</a>
          </div>

          <div class="widget-headers" style="margin-top: 40px;">
            <div class="panel-body">
              <div class="widget-icon">
                <img src="/img/summary_icons/new_document_add.png">
              </div>
              <a ui-sref="dashboard.reports({tabName: ''})" style="color: #222222">New Documents Added</a>
            </div>
          </div>
          <div class="widget-data">
            <div class="panel panel-default">
              <div class="panel-body">
                <div class="title">
                  Novo Granted Orphan Status for Ph2 T1DM Anti-IL-21 + Victoza
                </div>
                <div class="content">
                  The GLP-1RA class remains recommended above SGLT-2i
                </div>
              </div>
              <div class="footer-btns">
                  <button class="btn btn-default btn-xs">Adocia</button>
                  <button class="btn btn-default btn-xs">Lilly</button>
                  <button class="btn btn-default btn-xs">Hanml</button>
                  <button class="btn btn-default btn-xs">Insulin</button>
                  <a href="#"><img src="/img/summary_icons/down_bg.png" class="pull-right"></a>
                </div>
            </div>

            <div class="panel panel-default">
              <div class="panel-body">
                <div class="title">
                  Adocia Initiates Two New Projects for Treatment of T1DM
                </div>
                <div class="content">
                  Lonis Reports Positive Ph2 Result for LONIS-GCGR-Rx.
                </div>
              </div>
              <div class="footer-btns">
                  <button class="btn btn-default btn-xs">Lixisenatide</button>
                  <button class="btn btn-default btn-xs">GLP-1</button>
                  <a href="#"><img src="/img/summary_icons/down_bg.png" class="pull-right"></a>
                </div>
            </div>

            <div class="panel panel-default">
              <div class="panel-body">
                <div class="title">
                  Sanofi's Soliqua Now Available in US Pharmacies
                </div>
                <div class="content">
                  Lilly Announces Changes in its Organizational Structure
                </div>
              </div>
              <div class="footer-btns">
                  <button class="btn btn-default btn-xs">Novo Nordisk</button>
                  <button class="btn btn-default btn-xs">Lilly</button>
                  <button class="btn btn-default btn-xs">Trail Data</button>
                  <button class="btn btn-default btn-xs">Guidelines</button>
                  <a href="#"><img src="/img/summary_icons/down_bg.png" class="pull-right"></a>
                </div>
            </div>
          </div>
        </div>
        <div class="col-md-3 col-sm-3 col-xs-3">
          <div class="widget-headers">
            <div class="panel-body">
              <div class="widget-icon">
                <img src="/img/summary_icons/trending.png">
              </div>
              <a ui-sref="dashboard.tracksocial({tabName: ''})">Trending Topics</a>
            </div>
          </div>
          <div class="widget-data">
            <div class="panel panel-default">
              <div class="panel-body">
                <ul class="list-group">
                  <li class="list-group-item">Diabetes</li>
                  <li class="list-group-item">Xultrophy</li>
                  <li class="list-group-item">Sanofi</li>
                  <li class="list-group-item">Diabetes</li>
                  <li class="list-group-item">Xultrophy</li>
                  <li class="list-group-item">Intarcia</li>
                  <li class="list-group-item">Implantable</li>
                  <li class="list-group-item">Prophylatic</li>
                  <li class="list-group-item">Therapeutic</li>
                  <li class="list-group-item">Gatesfoundation</li>
                  <li class="list-group-item">Preventior</li>
                  <li class="list-group-item">Itca</li>
                  <li class="list-group-item">Peptide</li>
                  <li class="list-group-item">Collaboration</li>
                </ul>
              </div>
            </div>
            <a ui-sref="dashboard.tracksocial({tabName: ''})" class="pull-right" style="font-size: smaller;">View More</a>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>
